Rosuvastatin-acenocoumarol interaction

Clinical Therapeutics

Volumn 27, Issue 6, 2005, Pages 782-784

  Mondillo, Sergio ^a   Ballo, Piercarlo ^b   Galderisi, Maurizio ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Acenocoumarol; Anticoagulants; Interaction; Rosuvastatin; Statins

Indexed keywords

ACENOCOUMAROL; ROSUVASTATIN;

ADULT; ANAMNESIS; ANTICOAGULATION; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; HUMAN; LABORATORY TEST; LEG DISEASE; LONG TERM CARE; MALE; MUSCLE HEMATOMA;

EID: 27744527548     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.06.007     Document Type: Article

References (26)

1. Futterman LG, Lemberg L. Stroke risk, cholesterol and statins. Am J Crit Care. 1999;8:416-419.
2. Pearson TA. The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease. Am J Cardiol. 2004;94:4F-8F.
3. Andrus MR. Oral anticoagulant drug interactions with statins: Case report of fluvastatin and review of the literature. Pharmacotherapy. 2004; 24:285-290.
4. Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet. 2002;41:343-370.
5. Omar MA, Wilson JP. FDA adverse event reports on statin-associated rhabdomyolysis. Ann Pharmacother. 2002;36:288-295.
6. Trilli LE, Kelley CL, Aspinall SL, Kroner BA. Potential interaction between warfarin and fluvastatin. Ann Pharmacother. 1996;30:1399-1402.
7. Kline SS, Harrell CC. Potential warfarin-fluvastatin interaction. Ann Pharmacother. 1997;31:790.
8. Ahmad S. Lovastatin. Warfarin interaction. Arch Intern Med. 1990; 150:2407.
9. Hoffman HS. The interaction of lovastatin and warfarin. Conn Med. 1992;56:107.
10. Iliadis EA, Konwinski MF. Lovastatin during warfarin therapy resulting in bleeding. Pa Med. 1995;98:31.
11. Gaw A, Wosomu D. Simvastatin during warfarin therapy in hyperlipoproteinaemia. Lancet. 1992;340: 979-980.
12. Hickmott H, Wynne H, Kamali F. The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements. Thromb Haemost. 2003;89:949-950.
13. Lin JC, Ito MK, Stolley SN, et al. The effect of converting from pravastatin to simvastatin on the pharmacodynamics of warfarin. J Clin Pharmacol. 1999;39:86-90.
14. Barry M. Rosuvastatin-warfarin drug interaction. Lancet. 2004;363: 328.
15. Stern R, Abel R, Gibson GL, Besserer J. Atorvastatin does not alter the anti-coagulant activity of warfarin. J Clin Pharmacol. 1997;37:1062-1064.
16. Trenque T, Choisy H, Germani ML. Pravastatin: Interaction with oral anticoagulant? BMJ. 1996;312:886.
17. Grau E, Perella M, Pastor E. Simvastatin-oral anticoagulant interaction. Lancet. 1996;347:405-406.
18. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Phamacol Ther. 1981;30:239-245.
19. Martin J, Krum H. Cytochrome P450 drug interactions within the HMC-CoA reductase inhibitor class: Are they clinically relevant? Drug Saf. 2003;26:13-21.
20. Lennemas H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet. 1997;32:403-425.
21. Summary of product characteristics for drug specialties based on rosuvastatin. Available at: http://www. ministerosalute.ic/imgs/C_17_notaInf_ 40_listaFile_itemName_1_file.pdf. Accessed April 22, 2005.
22. British National Formulary. 49th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2005. Available at: www.bnf.org. Accessed April 22, 2005.
23. Ridker PM, for the JUPITER Study Group. Rosuvascatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Rationale and design of the JUPITER trial. Circulation. 2003;108:2292-2297.
24. Cheng JW. Rosuvastatin in the management of hyperlipidemia. Clin Ther. 2004;26:1368-1387.
25. Ballantyne CM, Miller E, Chitra R. Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: A randomized, open-label, multicenter trial. Clin Ther. 2004;26:1855-1864.
26. Jones PH, Hunninghake DB, Ferdinand KC, et al, for the Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: Additional results from the STELLAR trial [published correction appears in Clin Ther. 2005;27:142]. Clin Ther. 2004;26: 1388-1399.